BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 12761644)

  • 21. [Comprehensive approach to treating cranial ependymomas in children].
    Trunin IuIu
    Zh Vopr Neirokhir Im N N Burdenko; 2007; (3):40-7. PubMed ID: 18041213
    [No Abstract]   [Full Text] [Related]  

  • 22. Intracranial ependymoma: factors affecting outcome.
    Massimino M; Buttarelli FR; Antonelli M; Gandola L; Modena P; Giangaspero F
    Future Oncol; 2009 Mar; 5(2):207-16. PubMed ID: 19284379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metastasizing anaplastic ependymoma in an adult. Chromosomal imbalances, metabolic and gene expression profiles.
    Lopez-Gines C; Gil-Benso R; Faus C; Monleon D; Mata M; Morales JM; Cigudosa JC; Gonzalez-Darder J; Celda B; Cerda-Nicolas M
    Histopathology; 2009 Mar; 54(4):500-4. PubMed ID: 19309408
    [No Abstract]   [Full Text] [Related]  

  • 24. Ependymoma: an update.
    Zacharoulis S; Moreno L
    J Child Neurol; 2009 Nov; 24(11):1431-8. PubMed ID: 19841430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of morphology of ependymoma in children to prognosis.
    Rorke LB
    Prog Exp Tumor Res; 1987; 30():170-4. PubMed ID: 3628803
    [No Abstract]   [Full Text] [Related]  

  • 26. Predicting which children are at risk for ependymoma relapse.
    Sowar K; Straessle J; Donson AM; Handler M; Foreman NK
    J Neurooncol; 2006 May; 78(1):41-6. PubMed ID: 16575538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microarray analysis of pediatric ependymoma identifies a cluster of 112 candidate genes including four transcripts at 22q12.1-q13.3.
    Suarez-Merino B; Hubank M; Revesz T; Harkness W; Hayward R; Thompson D; Darling JL; Thomas DG; Warr TJ
    Neuro Oncol; 2005 Jan; 7(1):20-31. PubMed ID: 15701279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The molecular biology of ependymomas.
    Hamilton RL; Pollack IF
    Brain Pathol; 1997 Apr; 7(2):807-22. PubMed ID: 9161731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multidisciplinary management of intracranial ependymoma.
    Chan MD; McMullen KP
    Curr Probl Cancer; 2012; 36(1):6-19. PubMed ID: 22325305
    [No Abstract]   [Full Text] [Related]  

  • 30. Loss of chromosome 1 in myxopapillary ependymoma suggests a region out of chromosome 22 as critical for tumour biology: a FISH analysis of four cases on touch imprint smears.
    Tamiolakis D; Papadopoulos N; Venizelos I; Lambropoulou M; Nikolaidou S; Bolioti S; Kiziridou A; Manavis J; Alexiadis G; Simopoulos C
    Cytopathology; 2006 Aug; 17(4):199-204. PubMed ID: 16879268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Posterior fossa tumors in children: clinical aspects].
    Reed UC
    Rev Hosp Clin Fac Med Sao Paulo; 1982 Oct; 37(5):219-27. PubMed ID: 7170577
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pediatric ependymomas: Current diagnosis and therapy].
    Frappaz D; Vasiljevic A; Beuriat PA; Alapetite C; Grill J; Szathmari A; Faure-Conter C
    Bull Cancer; 2016 Oct; 103(10):869-879. PubMed ID: 27717499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing 'second-look' tumour resectability in childhood posterior fossa ependymoma-a centralised review panel and staging tool for future studies.
    Millward CP; Mallucci C; Jaspan T; Macarthur D; Heyward R; Cox T; Chong K; Grundy RG
    Childs Nerv Syst; 2016 Nov; 32(11):2189-2196. PubMed ID: 27585992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New innovations and developments for glioma treatment.
    Croteau D; Mikkelsen T; Rempel SA; Bogler O; Rosenblum M
    Clin Neurosurg; 2001; 48():60-81. PubMed ID: 11692657
    [No Abstract]   [Full Text] [Related]  

  • 35. Undifferentiated sarcoma arising in the brain, 23 years after curative treatment of an ependymoma.
    Hofer S; Seeger H; Rordorf T; Knuth A; Janzer R
    J Neurooncol; 2005 May; 72(3):239. PubMed ID: 15937646
    [No Abstract]   [Full Text] [Related]  

  • 36. Posterior fossa ependymoma: current insights.
    Thompson YY; Ramaswamy V; Diamandis P; Daniels C; Taylor MD
    Childs Nerv Syst; 2015 Oct; 31(10):1699-706. PubMed ID: 26351223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression alterations define unique molecular characteristics of spinal ependymomas.
    Lourdusamy A; Rahman R; Grundy RG
    Oncotarget; 2015 Aug; 6(23):19780-91. PubMed ID: 25909290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Malignant gliomas. Oncogenic considerations].
    Pérez-Ortiz L; Zaldívar-Vaillant T; Tamayo-Suárez JD
    Rev Neurol; 2000 Jul 1-15; 31(1):49-52. PubMed ID: 10948584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uncommon pediatric tumors of the posterior fossa: pathologic and molecular features.
    Dunham C
    Childs Nerv Syst; 2015 Oct; 31(10):1729-37. PubMed ID: 26351226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cortical ependymoma or monomorphous angiocentric glioma?
    Lum DJ; Halliday W; Watson M; Smith A; Law A
    Neuropathology; 2008 Feb; 28(1):81-6. PubMed ID: 18021197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.